In summary, these data demonstrate that inhibition of the residual active GSK3α/β by SB 216763 differentially modulates the progression and cytokine expression profiles of HNSCC cells, independently of TLR3 and TLR4 induced NFkB signalling. The gene discussed is TLR4; the disease is head and neck squamous cell carcinoma.